The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma

被引：63

作者：

Garcia-Reyes, Balbina ^{[1
]}

Kretz, Anna-Laura ^{[1
]}

Ruff, Jan-Philipp ^{[1
]}

von Karstedt, Silvia ^{[2
,3
]}

Hillenbrand, Andreas ^{[1
]}

Knippschild, Uwe ^{[1
]}

Henne-Bruns, Doris ^{[1
]}

Lemke, Johannes ^{[1
]}

机构：

[1] Ulm Univ Hosp, Dept Gen & Visceral Surg, Albert Einstein Allee 23, D-89081 Ulm, Germany

[2] Univ Hosp Cologne, Dept Translat Genom, Weyertal 115b, D-50931 Cologne, Germany

[3] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2018年 / 19卷 / 10期

关键词：

pancreatic cancer; pancreatic ductal adenocarcinoma; CDK; cyclin-dependent kinase; INHIBITOR DINACICLIB MK-7965; CHRONIC LYMPHOCYTIC-LEUKEMIA; TRAIL-INDUCED APOPTOSIS; I DOSE-ESCALATION; CELL-CYCLE; PROTEIN-KINASE; S-PHASE; DNA-DAMAGE; REPLICATION STRESS; ANTITUMOR-ACTIVITY;

D O I：

10.3390/ijms19103219

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The family of cyclin-dependent kinases (CDKs) has critical functions in cell cycle regulation and controlling of transcriptional elongation. Moreover, dysregulated CDKs have been linked to cancer initiation and progression. Pharmacological CDK inhibition has recently emerged as a novel and promising approach in cancer therapy. This idea is of particular interest to combat pancreatic ductal adenocarcinoma (PDAC), a cancer entity with a dismal prognosis which is owed mainly to PDAC's resistance to conventional therapies. Here, we review the current knowledge of CDK biology, its role in cancer and the therapeutic potential to target CDKs as a novel treatment strategy for PDAC.

引用

页数：28

共 249 条

[11] Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer [J].

Attardi, LD ;

de Vries, A ;

Jacks, T .

ONCOGENE, 2004, 23 (04) :973-980

[12] A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy [J].

Awan, Farrukh T. ;

Jones, Jeffrey A. ;

Maddocks, Kami ;

Poi, Ming ;

Grever, Michael R. ;

Johnson, Amy ;

Byrd, John C. ;

Andritsos, Leslie A. .

ANNALS OF HEMATOLOGY, 2016, 95 (07) :1137-1143

[13] Human CDK18 promotes replication stress signaling and genome stability [J].

Barone, Giancarlo ;

Staples, Christopher J. ;

Ganesh, Anil ;

Patterson, Karl W. ;

Bryne, Dominic P. ;

Myers, Katie N. ;

Patil, Abhijit A. ;

Eyers, Claire E. ;

Maslen, Sarah ;

Skehel, J. Mark ;

Eyers, Patrick A. ;

Collis, Spencer J. .

NUCLEIC ACIDS RESEARCH, 2016, 44 (18) :8772-8785

[14] Mammalian G1- and S-phase checkpoints in response to DNA damage [J].

Bartek, J ;

Lukas, J .

CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (06) :738-747

[15] Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints [J].

Bartkova, Jirina ;

Rezaei, Nousin ;

Liontos, Michalis ;

Karakaidos, Panagiotis ;

Kletsas, Dimitris ;

Issaeva, Natalia ;

Vassiliou, Leandros-Vassilios F. ;

Kolettas, Evangelos ;

Niforou, Katerina ;

Zoumpourlis, Vassilis C. ;

Takaoka, Munenori ;

Nakagawa, Hiroshi ;

Tort, Frederic ;

Fugger, Kasper ;

Johansson, Fredrik ;

Sehested, Maxwell ;

Andersen, Claus L. ;

Dyrskjot, Lars ;

Orntoft, Torben ;

Lukas, Jiri ;

Kittas, Christos ;

Helleday, Thomas ;

Halazonetis, Thanos D. ;

Bartek, Jiri ;

Gorgoulis, Vassilis G. .

NATURE, 2006, 444 (7119) :633-637

[16] CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1 [J].

Bartkowiak, Bartlomiej ;

Liu, Pengda ;

Phatnani, Hemali P. ;

Fuda, Nicholas J. ;

Cooper, Jeffrey J. ;

Price, David H. ;

Adelman, Karen ;

Lis, John T. ;

Greenleaf, Arno L. .

GENES & DEVELOPMENT, 2010, 24 (20) :2303-2316

[17] Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors [J].

Bendris, Nawal ;

Lemmers, Benedicte ;

Blanchard, Jean Marie .

CELL CYCLE, 2015, 14 (12) :1786-1796

[18] Cell-specific responses to loss of cyclin-dependent kinases [J].

Berthet, C. ;

Kaldis, P. .

ONCOGENE, 2007, 26 (31) :4469-4477

[19] Cdk2 knockout mice are viable [J].

Berthet, C ;

Aleem, E ;

Coppola, V ;

Tessarollo, L ;

Kaldis, P .

CURRENT BIOLOGY, 2003, 13 (20) :1775-1785

[20] Chk1 Inhibits E2F6 Repressor Function in Response to Replication Stress to Maintain Cell-Cycle Transcription [J].

Bertoli, Cosetta ;

Klier, Steffi ;

McGowan, Clare ;

Wittenberg, Curt ;

de Bruin, Robertus A. M. .

CURRENT BIOLOGY, 2013, 23 (17) :1629-1637

← 1 2 3 4 5 6 7 8 9 10 →